Status:
COMPLETED
Couples Health Project: Couples-based Intervention to Reduce Drug Use and HIV Transmission Risk
Lead Sponsor:
Hunter College of City University of New York
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Risk Behavior
Drug Use
Eligibility:
MALE
18-29 years
Phase:
NA
Brief Summary
This project tests the feasibility, acceptability, and preliminary efficacy of the Couples Health Project (CHP). CHP is a brief (3-session) couples-based Motivational Interviewing intervention which a...
Detailed Description
This study aims to evaluate a couples-based intervention with an integrated focus on drug use and HIV prevention, including uptake of and adherence to PrEP. The investigators will recruit a sample of ...
Eligibility Criteria
Inclusion
- At least one member of the couple must be 18 to 29 years of age
- Both members assigned male gender at birth and currently identify as male
- At least one member of the couple reports an HIV-negative serostatus
- Couple has been together for at least 3 months
- The use of at least one of the following substances in the past 30 days (only one partner): marijuana, cocaine/crack, amphetamines, ecstasy, GHB, ketamine, nitrates, prescriptionn drug misuse
- At least one member of the couple, in the past 30 days, had condomless anal sex (CAS) with a casual partner and/or CAS with a non-monogamous or serodiscordant main partner.
- Both members must be able to communicate in English
- Both members must reside in the NYC metro area
Exclusion
- Either member of the couple reports IPV, which is defined as serious physical or sexual violence that occurs outside the context of consensual bondage or sado-masochistic sexual play, which results in concerns of safety.
- Inconsistencies between information provided in the eligibility screener and the in-person meeting or any issues that might hinder participation. The couple may also be deemed ineligible if participant responses are sufficiently inconsistent to call into question the validity of their individual responses
- The couple reports a sero-concordant HIV-positive serostatus
- Unstable, serious psychiatric symptoms (assessed at Baseline)
- Currently suicidal/homicidal
- Evidence of gross cognitive impairment
Key Trial Info
Start Date :
March 6 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 14 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03386110
Start Date
March 6 2018
End Date
September 14 2020
Last Update
August 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for HIV Educational Studies and Training
New York, New York, United States, 10018